Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced the completion of its acquisition of Pathway Capital Management (“Pathway”), a global provider of private market solutions for institutional and wealth markets.
The strategic acquisition significantly expands Clearlake’s private markets platform, adding complementary capabilities and reinforcing its position as a leading diversified alternative asset manager. Founded in 1991, Pathway manages more than $95 billion in assets and brings a proven track record across private equity, private credit, infrastructure, secondaries and co-investments through customized private markets programs and multi-investor funds. The combination will bolster Clearlake’s private credit origination capabilities, broaden distribution across institutional and private wealth channels, and enhance the firm’s ability to meet growing demand for bespoke private markets strategies. The combined platform represents over $185 billion in assets under management with more than 500 global employees. Pathway will continue to operate under its existing brand as part of Clearlake’s broader private markets platform and Pathway’s team will continue to be led by James Chambliss, Richard Mazer, and Alex Casbolt.
“This combination marks an important milestone in Clearlake’s continued development as a leading global alternatives platform,” said José E. Feliciano and Behdad Eghbali, Co-Founders and Managing Partners at Clearlake. “By bringing together complementary capabilities, deep private markets expertise, and shared cultural values, we are enhancing our ability to serve investors worldwide with broader, more tailored solutions across an increasingly dynamic market landscape. We are thrilled to welcome the Pathway team to Clearlake.”
“We are excited to begin this next chapter with Clearlake,” said Pathway’s James Chambliss, Richard Mazer, and Alex Casbolt. “Clearlake’s scale and shared commitment to client servicing will further strengthen our ability to deliver differentiated private markets solutions to investors globally, while continuing to operate under the Pathway brand our clients know and trust.”
About Clearlake
Clearlake Capital is a leading global alternative asset manager founded in 2006 with over $185 billion of assets under management. Clearlake offers a broad range of investment solutions across private equity, credit, infrastructure, secondaries, co-investments, and other related private market strategies. Clearlake seeks to partner with experienced management teams by providing patient, long-term capital to businesses across multiple sectors. The firm aims to drive value through its active, hands-on operating approach, O.P.S.® (Operations, People, Strategy), which combines deep operational expertise with strategic and talent-focused initiatives. Headquartered in Santa Monica, Clearlake maintains 13 offices across the Americas, Europe, Asia, and the Middle East. For more information, please visit clearlake.com or follow us on LinkedIn.
About Pathway
Pathway is a leading private market solutions provider with over $95 billion in assets under management from private equity, private credit, and infrastructure mandates serving the needs of institutional and wealth investors worldwide. Formed in 1991, Pathway creates and manages custom and multi-investor programs, investing in various private market strategies through primaries, secondaries, and co-investments. Pathway’s investment professionals have participated in the development of 135 private market portfolios, committing more than $135 billion across a wide variety of private market strategies. Pathway is headquartered in Irvine, California, with additional offices in Providence, London, Munich, and Hong Kong. For more information, please visit pathwaycapital.com or follow us on LinkedIn.
随机文章
热门文章

V1.0重磅发布!四维天穹绘构低空天路
倒计时21天!2026未来医疗医药100强大会议程再刷新
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
TruMerit与Credivera为全球医疗保健专业人员颁发首批可验证数字证书
携手专精特新,筑基制造强国 | 埃克森美孚中国与凤宝重科缔结“鹏程伙伴”
Mevion Medical Systems与谭英综合医院合作,将先进的质子治疗引入越南
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcar
“兴火·燎原”总冠军诞生,云宏信息《金融高算力轻量云平台》登顶
泳池过滤器怎么选?揭开Waternics水武仕珍珠岩过滤器的“硬核密码”!